Agoracom Blog Home

Archive for the ‘All Recent Posts’ Category

INTERVIEW: QE2 Acquisition Corp. (QE: TSX-V) – Robust Growth Marks This Compelling Infrastructure Play

Posted by AGORACOM-JC at 9:51 AM on Monday, November 24th, 2014

QE: TSX-V

Robust Growth Marks This Compelling Infrastructure Play

Welcome to CEO Interviews a production of AGORACOM in which we speak to small cap CEOs and Executives about their companies.  With us today is Brent Buhler, VP Finance of QE2 Acquisition Corp.

  • Alberta-founded firm that acquires and grows well-managed, profitable, asset-backed, Alberta-based businesses in the infrastructure and utility service sectors.
  • More than just lip service, QE2 reported revenues of ~ $2.3M for the quarter ended July 31
  • Growth strategy is a mergers and acquisitions program which leverages the synergies that can be achieved by vertical and horizontal integration.

Hub On AGORACOM / Corporate Profile / Watch Interview Now!

Lexaria Launches Medical Advisory Board

Posted by AGORACOM-JC at 7:58 AM on Thursday, November 20th, 2014

 

KELOWNA, BC / November 20, 2014 / Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) is pleased to announce that it and joint venture partner Enertopia Corp (ENRT) have launched a formal Medical Advisory Board to educate and advocate on behalf of all those who have medical needs that may be able to be met through the understanding and use of medical marijuana or through the use of cannabidiol (CBD) extracted from Agricultural Hemp.

The Medical Advisor Board members specialize in various medical categories, and will work with health care professionals, patients, and prescribers of medical marijuana to promote greater understanding of medical marijuana and of CBD-enhanced products. There are believed by many to be a wide variety of medical conditions that might be positively affected either by medical marijuana or by CBD’s, but in many cases the accuracy of claims may not be well understood at this time.

In particular, the use of high-cannabidiol strains that have little or no psychoactive effects on the patient, are of interest for to alleviate many medical symptoms, according to existing studies and literature. Lexaria has already voluntarily established its own Canadian corporate policy of being unwilling to sell medical marijuana with more than 0.3% THC content to anyone under the age of 25, in line with much of the Canadian medical community.

Recreational use of Marijuana is illegal in Canada, and illegal at the federal level in the United States because of the THC content; this status has prevented or greatly reduced the opportunity for peer-reviewed scientific study. Still, there is growing evidence that there could be real medical benefits associated with either medical marijuana and/or the CBD’s within it. Despite the hurdles to conducting past research, there are 1,277 references today to Cannabidiol at research papers located at the US National Library of Medicine, National Institutes of Health website (www.pubmed.gov).

Many organizations are calling for additional research regarding medical marijuana. For instance the Arthritis Society in September announced it wants more research to study the impact of medical marijuana on pain, and that it is preparing to fund clinical studies. Jason McDougall, chair of the Arthritis Society’s scientific advisory committee and a pain researcher at Dalhousie University was quoted at that time saying, “I think it’s high time that we found something to help the 4.6-million Canadians living with arthritis and trying to do something to help.”

Lexaria hopes to announce its first meetings and/or conferences as soon as possible.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for opportunities that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana or alternative health businesses will provide any benefit to Lexaria. There is no assurance that any cannabidiol-based product will be accepted into the marketplace or have any positive impact upon Lexaria Corp. There is no assurance that and cannabidiol-based product will promote, assist, or maintain any beneficial human health conditions whatsoever.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Supreme Completes Private Placement for Aggregate Total of $1.78M

Posted by AGORACOM-JC at 7:49 PM on Monday, November 17th, 2014

VANCOUVER, BRITISH COLUMBIA–(Nov. 17, 2014) – NOT FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW.

Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (CSE:SL) is pleased to announce that it has closed the final tranche of its previously announced unit financing for gross proceeds of $815,893.44 (the “Financing“). At the final closing, Supreme issued 2,549,667 units (comprised of 2,549,667 common shares of the Company (“Common Shares“) and 1,274,834 Common Share purchase warrants (“Warrants“)) at a price of $0.32 per unit. Each Warrant is exercisable for one Common Share at a price of $0.50 per share prior to November 17, 2016, subject to an accelerated expiry period upon 30-days notice by the Company to the subscriber, if the Common Shares trade at or above $0.70 for any five (5) day period during the term of the Warrants. In aggregate, total gross proceeds raised from the first and second closings totalled $1,781,642.24 through the issuance of 5,567,632 Common Shares and 2,783,816 Warrants.

“Having raised almost double the proceeds that we initially sought when we announced our raise just three weeks ago, we’re pleased with the positive response we’ve had, and extremely gratified at the investment community’s ongoing interest in Supreme”, stated a director of the company. “With this raise now finalized, we have a strong balance sheet and are well-positioned to continue executing on our long-term growth strategy.”

The Company paid aggregate finder’s fees of $21,769.60 and issued 68,030 Warrants to certain arm’s-length parties in the connection with the subscriptions of certain subscribers who participated in the Financing.

The Common Shares and Warrants issued pursuant to the final tranche of the Financing are subject to a hold period that expires March 18, 2015. Following closing, Supreme has 76,031,197 Common Shares issued and outstanding.

The Company intends to use the aggregate proceeds of the Financing for the continuing development of the Company’s Kincardine facility and general working capital purposes.

FORWARD-LOOKING INFORMATION

This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. More particularly and without limitation, this news release contains forward‐looking statements and information relating to the use of proceeds of the Financing, as well as the Company’s corporate strategy. The forward‐looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan following the issuance of the required licenses by Health Canada. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward‐looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward‐looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and related regulations. Accordingly, readers should not place undue reliance on the forward‐looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward‐looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward‐looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

Supreme Pharmaceuticals Inc.
Investor Relations
(604) 674-2191
[email protected]
www.supreme.ca

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

AGORACOM Small Cap TV “Best Of The Best” – November 17, 2014

Posted by AGORACOM-JC at 7:12 PM on Monday, November 17th, 2014

AGORACOM Founder, George Tsiolis and Chief Market Commentator, Allan Barry Go Via Satellite to discuss and debate Allan’s Best picks this week. Companies Included on this week’s show are:

WHY IS JULY 11, 2013 SO IMPORTANT?

Allan and George have already put their viewers well ahead of the game by starting their weekly broadcasts on July 11, 2013 on the thesis that great small-cap companies were so oversold they could not be ignored. One look at the TSX Venture Index proves they hit the nail on the head … but that doesn’t come close to telling the whole story with most of their picks far outperforming an index bloated with zombie companies.

Find out which companies Allan and George like this week by watching the video below!

Want to catch up on previous shows?

Weekly “Best Of The Best” Summarizing The Best Picks From Our Daily Shows. Posted Every Friday Afternoon Watch Here

THIS WEEK’S SHOW SPONSORED BY THE FOLLOWING GREAT SMALL CAP COMPANY:


Neah Power Systems – Q&A Session Vol. 5 – November 13, 2014

Posted by AGORACOM-JC at 4:13 PM on Thursday, November 13th, 2014
Welcome to AGORACOM Q&A. We have invited Neah Power Systems Investors to ask questions which have been answered directly by management.With us today is Dr. Chris D’Couto President of Neah Power Systems, a developer of fuel cell power solutions using proprietary, award winning technology for the military, transportation, and portable electronic devices.

$50M+ Invested into Neah Power Systems

  • Intel Corporation, Novellus Systems, Four Tier 1 VCs, US Navy, NIST/ATP
  • award winning technology (Popular Science, MIT)

Hub On AGORACOM / Corporate Website / Watch Interview Now!
 

Lexaria Continues Transformation Into Alternative Health Sector

Posted by AGORACOM-JC at 8:07 AM on Wednesday, November 12th, 2014

 

Kelowna, British Columbia–(November 12, 2014) – Lexaria Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) announces has entered an agreement and has begun a staged acquisition of a corporation and its expertise in delivering Cannabidiol (CBD)-infused products. This marks a major milestone for Lexaria as it is both our first foray into the United States based on a product derived from legal industrial hemp; and it is also Lexaria’s first step into the large alternative health and wellness sector.

Lexaria has initially acquired 51% of PoViva Corp, and can ultimately acquire up to 75% of the company through staged transactions. PoViva literally means “Taking in Life” PoViva uses a patent pending process to bind active CBD ingredients with a lipid, allowing for a more efficient and comforting delivery of the CBD than competing products that do not have the benefit of our patent-pending process.

PoViva owns two patents pending that govern the process used to infuse the CBD into food products, and both patents pending are part of the acquisition. An initial cash payment has been made to PoViva and Lexaria currently has sufficient cash resources to completely fund and launch the acquisition. Lexaria does not require any equity financing to complete the transaction.

Founder of PoViva, Ms. Marian Washington lends her extensive leadership and knowledge of athletic physiology to the company. Marion has Master’s Degree in Biodynamics and Administration and was awarded an honorary doctorate from West Chester State College. For thirty years, Marian served as head women’s basketball coach of prominent division one university. Ms. Washington has been received into multiple Halls of Fame, received prominent athletic leadership awards, and coached national and international teams, including coaching the 1996 Olympic Women’s Basketball Team to a gold medal.

Michelle Reillo, PhD, the co-founder of PoViva and will drive production and new products within PoViva as the Product and Research Manager. Michelle has a BSc in Nursing; a MS in Gerontology; and a PhD in Education. She has extensive experience with both Federal and private proposal development and submission and research projects, including CDC, NIH, NCI, NIDA, and AmFar. She is a former Clinical Director of Hyperbaric Medical Clinic. Michelle is the author of AIDS Under Pressure and pioneered retroviral research in hyperbaric medicine and HIV/AIDS. She is the author of many highly regarded research papers in the medical community.

Lexaria will strive to make its name synonymous with rejuvenation and healthy living. Lexaria believes that feelings of good health are a luxury to be enjoyed by all and will introduce products aimed to provide comfort and well-being. We are currently conducting our investigation of entering several popular food and drink sectors where our patent-pending cannabidiol delivery might prove particularly popular. Lexaria will announce further developments as our product mix becomes finalized.

To begin, we expect to launch PoViva Teas as our first CBD-infused product using our patent-pending processes as quickly as possible. According to the Tea Association of the USA Inc, Americans consumed over 79 billion servings of tea in 2012, its popularity far outstripping any alternative health sector. On any given day, over 150 million Americans consume tea, and 84% of all tea consumed is black tea.

Globally, tea is the most widely consumed beverage in the world after water, with over 3 billion servings of tea per day. As part of the current business agreement, Lexaria has acquired a 3-year exclusive right to the patent-pending process to infuse CBD’s into all global markets outside of the USA. We will investigate all global initiatives that build and promote the PoViva by Lexaria brand.

For example, the combined hot beverage markets of coffee and tea together, globally, is $69.77 Billion expected in 2015, according to a 2010 report by Basu Majumder A., Bera B. and Rajan A.

Lexaria is beginning construction of an e-commerce website that will allow for direct online sales of PoViva teas and other products across the United States. Other sales channels, both domestic and international will also be pursued and developed as rapidly as possible. Pre-orders for PoViva Tea by Lexaria will be accepted soon.

Tea naturally contains no sodium and virtually no calories but does contain flavonoids which are naturally occurring compounds thought to have antioxidant properties. PoViva Tea by Lexaria will include non-psychoactive CBD compounds through our patent pending process. Studies have shown that persons who drink 3 or more cups of black tea per day, have a reduced risk of heart disease and stroke. (1) Various studies have shown that drinking tea can reduce the incidence of contracting cancers such as prostate, rectal, colon, and squamous cell carcinoma. (2) Other research has found that consuming antioxidants, such as those that are found in tea and in CBD’s, may result in a 69% lower likelihood of developing Parkinson’s disease.(3)

According to the US Department of Health and Human Services Patent number 6,630,507, Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia. Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention.”

Lexaria wishes to inform all stakeholders that it continues to pursue its Health Canada MMPR Licensed Producer status by way of its joint venture in Burlington Ontario with Enertopia Corp. Our goal of acquiring that license remains unchanged. However, in light of delays in the licensing process outside of our control, we continue to pursue opportunities to build shareholder value as functionally and rapidly as possible.

Lexaria will be announcing additional information on its product mix and business plan in the immediate future. Our goal is to begin producing cash flows from these initiatives as soon as possible; focused on the immediate opportunities in the CBD-sectors derived from already-legal hemp.

(1) Larsson SC, Virtamo J, Wolk A. Black tea consumption and risk of stroke in women and men. Ann Epidemiol. 2013 Mar; 23(3):157-60. (and Others)

(2) Su LJ, Arab L. Tea consumption and the reduced risk of colon cancer — results from a national prospective cohort study. Public Health Nutr. 2002 Jun; 5(3): 419-25. (and Others)

(3) Hu G, Bidel S, et al. Coffee and tea consumption and the risk of Parkinson’s disease. Mov Disord. 2007 Aug 21: [Epub ahead of print]

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:
Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana or alternative health businesses will provide any benefit to Lexaria. There is no assurance that PoViva Teas will be accepted into the marketplace or have any positive impact upon Lexaria Corp. There is no assurance that PoViva Teas will promote, assist, or maintain any beneficial human health conditions whatsoever.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Montreal’s first medical marijuana clinic opens doors

Posted by AGORACOM-JC at 3:17 PM on Tuesday, November 11th, 2014

Clinic serves as portal to legal access to medical cannabis

CBC News Posted: Nov 11, 2014 12:42 PM ET Last Updated: Nov 11, 2014 12:42 PM ET

Palliative care expert Dr. Michael Dworkind will serve as medical director of Santé Cannabis.Palliative care expert Dr. Michael Dworkind will serve as medical director of Santé Cannabis.

The first medical marijuana clinic in Quebec has opened its doors in Montreal.

The goal of Santé Cannabis is to evaluate patients for therapies using medical marijuana, said Adam Greenblatt, the clinics’s executive director.

“There’s about one million patients across Quebec who medicate with cannabis in some way or another,” Greenblatt told CBC’s Daybreak.

“But the large majority of them access their cannabis from illicit unregulated sources. So our goal really is to help facilitate access to legal sources of medical cannabis to eligible patients who meet certain qualifications.”

Santé CannabisSanté Cannabis is in Montreal’s Gay Village neighbourhood. (Kate McKenna/CBC)

The name, Santé Cannabis, is a play on the French term for the federal government department, Santé Canada, (Health Canada).

‘The purpose of our clinic is to serve as a portal to legal access to medical cannabis. We know that the demand is out there’– Adam Greenblatt, Santé Cannabis

Greenblatt has enlisted Dr. Michael Dworkind as the clinic’s medical director, while Dr. Marcia Gillman will serve his associate director.

Both are known for their work in palliative care at Montreal’s Jewish General Hospital.

Greenblatt plans to have five doctors working in the clinic by February 2015.

Patients who come to the clinic are asked to have a referral from their family doctor or treating physician.

He said the clinic follows the guidelines set out by Quebec’s Collège des Médecins on the prescription of medical cannabis.

$250 annual fee

Greenblatt says Quebec’s medical insurance system will cover the cost of the consultation by one of the clinic’s doctors.

After that, patients will have to pay a $250 annual fee for the uninsured services of the clinic.

Those services include help choosing a licensed cannabis producer and an appropriate marijuana strain for treatment, and help navigating through the medical marijuana system.

Greenblatt says Santé Cannabis is a private business, but the main motivation is not profit.

“The purpose of our clinic is to serve as a portal to legal access to medical cannabis,” said Greenblatt. “We know that the demand is out there.”

Source: http://www.cbc.ca/news/canada/montreal/montreal-s-first-medical-marijuana-clinic-opens-doors-1.2831175

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

CLIENT FEATURE: Robix (RZX: CSE) Revolutionary Oil Spill Clean Up Technology

Posted by AGORACOM-JC at 11:32 AM on Tuesday, November 11th, 2014

RZX: CSE

Highly Cost Effective – Clean Ocean Vessel

  • The COV’s rapid recovery rate and large on-board storage result in low per barrel recovery cost.
  • The COV’s simple design minimizes down time for repair and maintenance.
  • A two-man crew can be easily trained and the COV vessel can operate long hours without interruption
  • Construction of the first commercial Clean Ocean Vessel is progressing, with immanent launch anticipated

Design Versatility

  • COV’S can be scaled to meet various application requirements (sizes range from 10 Ft., 20 Ft., 40 Ft., 80 Ft., 100 Ft. (references to length of vessel
  • A standard 40-foot COV is 40 feet in length, 26 feet in width, and 12 feet in depth
  • The following page has a 3D visual description of a COV
  • Recently completed the engineering drawings for the Clean Ocean Vessel (COV) and ordered critical components to initiate construction on the COV

Recent Highlights

  • Creating a new business division, through a subsidiary entity, to enter into the marine industry.
  • Announced that Rick Carson, of Montreal, PQ, has agreed to join Robix as a Strategic Advisor.
  • Announced that it intends to enter into an agreement with Rayco Steel Inc., wherein Rayco shall work on completion of engineering construction drawings for the anticipated construction of the first Clean Ocean Vessel.

How the COV compares to the competition:

  • Rates of oil recovered and recovery-throughput efficiencies are noted as “oil rate of recovery” (ORR) and “recovery efficiency” (RE).
  • The water surface lifting force generated by the COV’s patented contra-rotating drums acts in a suction or pumping manner that increases the ORR compared to conventional skimmer systems and the RE of the COV is in the 90-97% range. This is competitive with best in class 21st century technology in terms of ORR and RE.
  • Further improvements to the ORR (in terms of gallons per minute) could easily catapult the COV to “top three” status, by increasing the surface area of the drums through design modifications without impairing the stability of the vessel which is inherent to the COV design.
  • When our competitors’ skimmer systems meet waves above 18 inches, they are forced to suspend service. The COV operates in rough sea conditions (as high as 8 feet waves), significantly out-performing its competitors, and stands in a class of its own.

Hub On AGORACOM / Corporate Website

 

CLIENT FEAUTRE: Newnote (NEU: CSE) Canada’s Only Publically Traded Bitcoin Company

Posted by AGORACOM-JC at 3:04 PM on Friday, November 7th, 2014

Why Newnote Financial?

  • Pioneering innovative crypto-currency related software products and services geared at this growing global market
  • Positioned as a leader in delivering opportunities for companies and businesses wishing to participate in the Bitcoin economy while continuing to create value for our shareholders and stakeholders
  • Developingits own philanthropic crypto-currency, opened a datacenter for Bitcoin mining, secured over 100 terahashes for its cloud hashing services, secured a Bitcoin ABM and is launching its own Bitcoin exchange in short order.

Recent Highlights

  • Entered into a partnership with PrimeBit KK, a duly registered Company in Japan to provide and market the Newnote Pure Trade Exchangeâ„¢ platform in Japan
  • Announced it has purchased an equity position in the crypto-currency payment processor Coinpayments Inc.
  • Entered into Strategic Partnership with Net-Cents to Enable Clients to Instantly Convert Crypto Currency to Fiat and Transfer Funds
  • Announced it has been retained by Silver Phoenix Resources Inc. (CSE: SP) to develop the worlds first Net Smelter Return (NSR) backed crypto-currency
  • Successfully development and launch of the first open-source gold-backed alternative crypto-currency, commissioned by Anthem Vault Inc. Anthem Vault is a leading technological innovator in the bullion markets and precious metals dealer offering fractional investment in one-kilo gold bars and COMEX-approved 1,000 oz. silver bars
  • Sold 44% of its 110 terahash cloud hashing capacity in four weeks, representing approximately $78,000 in gross sales

Dedicated bitcoin mining Colocation Data Center

  • Secure underground Canadian facility is designed to handle the need for power and cooling for even the most powerful mining equipment.
  • Facility runs on 100% renewable energy, and has world-class security and energy infrastructure.
  • Miners can host their energy intensive mining equipment, which company will install in our facility, and they can remotely manage and mine Bitcoin or various altcoins of their choosing.

Growing network of ABM machines will allow people to conveniently buy bitcoin using their local fiat currency

Comapny ABM is quick and flexible. Some key advantages:

  • Fiat to Bitcoin in fifteen seconds
  • Accepts notes from over 200 countries
  • Supports leading exchanges, wallets and price feeds
  • Coded and audited by network security experts
  • Intuitive and simple user interface

Physical security is a priority, and the ABM has an internal steel vault that can be securely bolted to wall, stand, or countertop.

Charity Coin

  • Bringomg a new source of revenue for global charities.
  • When CryptoAid generates a coin, part of the currency will go to the miner and part goes to a pool of charities chosen by the CryptoAid community.

QE2 Acquisition Corp (QE: TSX-V) Robust Growth Marks This Compelling Infrastructure Play

Posted by AGORACOM-JC at 2:11 PM on Wednesday, November 5th, 2014

“Albertans created QE2 Acquisition Corp. with the true Alberta spirit of determination and the desire to create opportunity within the local economy through innovative vision and hard work. It was an idea six years in the making, formed while living and working within the province’s rural towns and urban centers. The relationships that were forged during this period would eventually culminate to form QE2 – from influential finance professionals to research analysts, salespeople and marketers, to business owners and families. QE2 is a company forged by a group of organized, motivated and extraordinary people with a vision to do extraordinary things.”

QE2 Acquisition Corp.’s Robust Growth Marks This Compelling Infrastructure Play

QE2 Acquisition Corp. (formerly Crowsnest Acquisition Corp.. TSXV: CAW.P) recently announced that it has closed its qualifying transaction by way of Crowsnest purchasing all of the issued and outstanding common shares in the capital of QE2 Acquisition Corp., and warrants to purchase QE2 Acquisition Corp. shares. This resulted in QE2 Acquisition Corp. becoming a wholly-owned subsidiary of Crowsnest. The combined entity changed its name to QE2 Acquisition Corp and trades under the symbol (TSXV: QE). QE2 Acquisition Corp., “QE2” has exactly what investors are looking for–positive normalized cash flow, a strong, low-risk growth profile through acquisitions and good financial visibility. QE2 has these attributes and more, a company with solid margins, closely tied to one the strongest economies in North America– Alberta, Canada. Canadians have been well aware of the booming economy in Alberta for years, now Europeans and Americans are looking for investment opportunities in Alberta as well.

QE2 truly has the best of both worlds, a growing, diversified portfolio of low-risk business, driven by strong growth markets in Alberta. Clients are municipalities, major utility and construction companies that primarily depend on general economic and population growth rather than cyclical factors. Current acquisition targets have a proven track-record of bottom line growth. Investors in this dynamic company receive exposure to infrastructure-focused companies that have proved resilient across a wide spectrum of market conditions. The secret sauce, which I will get into in more detail later, is the powerful combination of enhanced access to capital for growth constrained target companies and the opportunity for synergies among portfolio companies over time.

I’ve met with and spoken to some key people and I know the company’s new CFO Robert Harding from his time as CFO of a billion dollar oil sands company. This team has a tremendous skill set and they get things done. Further, QE2 has attracted a strong base of committed investors. CEO Mike Belantis said,

“We aim to grow QE2 through accretive acquisitions, organic growth from synergies realized by vertical and horizontal integration opportunities, sales and marketing channel expansion and access to available capital. The objective is to grow QE2 to $100 million in annual revenues by 2018.” [Please see Management Bios below].

Alberta, Canada Hard to Find a Better Place to Invest

Before I launch into the exciting story unfolding for QE2, it’s vitally important to understand the economic strength of Alberta’s economy. If one wanted to start a new business anywhere in North America, Alberta would be at the top of the list. There are several websites that describe Alberta’s vibrant economy, but I believe that a June, 2014 report from RBC summarizes the situation especially well. Please consider the following four quotes from that report,

“The contrast between booming conditions in one province (Alberta) and more moderate pace of growth everywhere else in the country rarely has been as stark, with Alberta this year far outpacing all other provincial economies. We expect all provincial economies will grow in 2014. Alberta will far outpace all others…Virtually every indicator continues to point toward booming conditions in the province. We expect this boom to continue. The bright job prospects in the province represent a powerful magnet to attract workers from outside the province—from both other provinces and countries—and strong immigration in turn will remain a main conduit to growth.”

“Alberta’s economy is in a class by itself in Canada. It has grown by an average growth rate of 4.3% in the past four years or almost twice the national average during that time. Last year, it grew by an estimated 3.7%, which would be a very strong rate that we expect will be replicated in 2014. Not only would this rate place Alberta far atop the provincial growth rankings this year, but also it would make it the lone province above the 2014 national average of 2.4%—a feat without precedent in the history going back to the early 1980s.”

“At its core, brisk activity in Alberta finds much of its source in the booming energy sector with massive investment in the oil sands still ongoing and crude oil production rising rapidly. More and more, the expansion is being fuelled by gains in a broader spectrum of economic sectors. Very strong population growth—the strongest seen in 30 years in the province—for instance, pumps up demand for housing and a wide array of consumer goods and services.”

“Almost everywhere we look, we see signs of a booming economy. Merchandise exports were up 16.0% year over year in the first quarter. Sales of manufacturers, wholesalers, and retailers were up 8.4%, 5.2%, and a very strong 10.0%, respectively, on the same basis. Increases in crude oil production were in the vicinity of 8% early this year. Housing starts stood 12.0% above year-ago levels in the first four months of 2014. Non-residential building construction climbed a solid 8.5% in the first quarter from the same period in 2013. In all this, the private sector remained in hiring mode, thereby boosting total employment by 3.3% compared to a year ago. Indeed, Alberta’s economic performance continues to impress and appears to be comfortably seated in the driver’s seat to drive growth in Canada.”

In pouring over the substantial amount of data in the RBC report, one thing that also stands out is Alberta’s unemployment rate in fiscal 2015 is forecast  to be 3.9% vs. 6.6% for Canada as a whole. A 3.9% unemployment rate is one third that of western Europe!

An investment in QE2 is like an investment in Alberta on steroids. QE2 is penetrating this booming economy with targeted acquisitions of private companies at very attractive valuations. Once these acquisitions are integrated, which is typically easy because the businesses are largely run autonomously, the whole becomes worth substantially more than the sum of the parts. Private companies frequently lack access to growth capital and debt financing. As a growing public company with committed stakeholders, QE2 has ready access to both and will use a prudent mix of cash, equity and debt to continue acquiring new businesses. Each acquisition will not only make the company larger and stronger, but will also diversify revenues and profits. This roll-up strategy of attractive, but growth constrained companies into a vehicle that can comfortably utilize debt and share best practices across all portfolio companies is a proven model in many industries.

How a Portfolio of Otherwise Boring Companies Adds Up to a High-Growth Investment Vehicle

QE2’s strategy is to acquire infrastructure-focused service providers in Alberta and improve their performance through superior operations management and business plan execution. QE2 has already completed two private company acquisitions. Pillar Contracting was acquired in October, 2013 with 2013 normalized EBITDA of $0.56 million. The implied valuation of Pillar Contracting was an attractive 2.4x EV/EBITDA. Primary services of portfolio company Pillar include; street light bulb replacement and post painting, safety testing for street light integrity, traffic lights maintenance and flagging services, among other things. Pillar had a 16 year history of success and growth. Importantly, the Founder has agreed to continue to operate the business, a common theme among acquired portfolio companies. As part of QE2, Pillar has a strong customer base including major utility companies and municipalities in Alberta and Saskatchewan. Pillar offers QE2 access to both expansion into Saskatchewan (and possibly Manitoba) as well as possible expansion into the private sector with a focus on parking lots, transmission boxes, cable boxes and oversized loads. Therefore, like QE2’s other portfolio business and acquired businesses to follow, low-risk, high visibility recurring revenue streams through service and maintenance.

Candesto Enterprises was acquired in April, 2014. Highlights of this portfolio company is that it had 2013 EBITDA of $1.5 million, implying an EV/EBITDA multiple of just 1.8x. Primary services include, assembly and installation of highway signs, guardrails and miscellaneous fencing installation. Camdesto had a successful operating history of over 20 years and the Founder is willing to stay for another five years. Therefore QE2 management expects consistent margins and operating performance in the future. Candesto’s customer base includes municipalities and general contractors. Given Candesto’s experience and efficiency in guardrails and signage installation, direct competitors are likely to subcontract the company’s services to the benefit of QE2 overall. These two acquisitions are instructive, steady growth, solid margin companies on their own, but combined with other portfolio companies, ample opportunities for synergies arise. The client base of each acquired company instantly becomes customer targets for all of QE2’s portfolio companies.

Synergies Could be Significant Over Time

Another example of synergies that can be exploited is in the area of operations management and equipment/facilities maintenance and procurement. Centralizing these key functions across a much larger base provides economies of scale and opportunities to cut costs and enhance margins. Even just a 5% margin boost from an acquired company would make a big difference as the benefit to the bottom line flows through year after year. Importantly, each portfolio company will have increased access to growth capital from its QE2 parent, meaning that BOTH margins and the top line should grow faster and more sustainably than they would as private standalone companies. That’s a prime reason why QE2 can acquire companies at attractive valuations…they have so much to offer the selling companies that it’s a win-win for everyone.

Valuation 

QE2 is new to the market, but there are a number of comparable companies to consider when valuing the company. The average Enterprise Value, “EV”/EBITDA ratio of peer companies is roughly 5x-6x. By comparison QE2 estimates its 2015 EV/EBITDA ratio will be 5.2x based on its two closed acquisitions. Recall, QE2’s two portfolio companies, Pillar and Candesto were acquired at implied EV/EBITDA ratios of 2.4x and 1.8x, respectively. This is at the lower end of the range of company guidance to make acquisitions of companies at an EV/EBITDA ratio of 2x-4x.

Therefore, I think that with additional accretive acquisitions the valuation gap to peers might grow, but as QE2 establishes itself as a true peer, the valuation gap will diminish by way of the company’s stock price rising. Especially as QE2 is the only pure-play infrastructure services company focusing on Alberta. With only 28.5 million basic shares outstanding, this is a stock that could move up quickly on good news. The last equity financing was done at $0.30 per share, so the market cap then was $8.6 million.

Importantly, the valuation really gets interesting if, for example, the company’s next acquisition is done at a 2.0x-3.0x EV/EBITDA multiple and this hypothetical deal doubled revenues and normalized EBITDA. An acquisition like this, if valued at a 5x-6x multiple by the market, would essentially double the value of QE2 to shareholders. Perhaps even more than double the equity value if a prudent amount of debt were to be used to close the acquisition. As long as too much debt is not deployed, rolling up private companies into a public vehicle is a proven strategy for success in multiple industries.

The company’s stated goal is to achieve $100 million in run-rate revenues by 2018. This might sound like a lofty goal, but with each portfolio company acquisition, QE2’s ability to prudently utilize debt and cash and raise success-based equity capital will only get stronger. Further economies of scale will accrue to the company. Synergies will be spread over a larger group of owned companies. And, of course, cross-selling opportunities will increase with each and every acquisition. All of the above does not even consider the possibilities of entering Manitoba and Saskatchewan in the future. Along the way, if QE2 executes on its plans, the company itself could become a takeover target.

Conclusion

In a stock market marked by the TSX Composite and S&P500 near all-time highs, it’s getting harder to find attractively valued growth companies that are also relatively low risk. QE2 is well positioned as an investment that has rapid growth potential, solid margins, the ability to harvest synergies and diversify, the opportunity to expand outside of Alberta– underpinned by the spectacular growth of Alberta’s booming economy. Fueled by a top-notch management team, QE2 is a company that should be on investor’s radar screens in the near future.

Management Team & Directors

Mihali (Mike) Belantis, CEO and Director

Mr. Belantis has more than 15 years’ experience identifying opportunities, investing and consulting for companies in both the private and public sectors. He has played a key role in developing the vision and implementing the initial foundation for many successful startups in some cases achieving market caps in excess of $300 million. As CEO, Mr. Belantis is involved in all aspects of QE2’s acquisitions, investments and new project initiatives. He also leads the team in setting the strategy and vision for the organization and articulating the road map for growth and a sustainable competitive advantage. Mr. Belantis is involved in identifying prospective targets and market opportunities; in the case of acquisitions, conducting due diligence, determining appropriate valuation and structure, developing strategy for and conducting negotiations, driving activities to closure and coordinating with other business units.
Rob Harding, CFO

Mr. Harding is a senior financial and management consultant with over 20 years of experience in start-ups through to multinational entities in the bulk highway transportation, engineering and construction and oil and gas industries. His experience includes accounting, risk management, strategic leadership, corporate finance, corporate governance, human resources and facilities management. Mr. Harding was most recently with Athabasca Oil Corporation where he held positions of Controller, Vice-President Finance & CFO and Vice-President Corporate Services where he was part of the leadership team that delivered a multi-billion dollar joint venture with Petro China, a $1.3 billion initial public offering, grew the oil sands contingent resources to over 10 billion barrels and expanded into light oil increasing production from inception to over 5,000 barrels of oil equivalent per day. Mr. Harding lived and worked internationally for over four years within the oil and gas industry with involvement in projects ranging from field operations for approximately 20,000 barrels per day production to construction and operation of multi-billion dollar LNG facilities. He received his Certified Management Accountant in 1996, a Masters of Business Administration in 2006 and recently earned the ICD.D designation as a graduate of the Institute of Corporate Directors. Mr. Harding currently serves on the board of directors and audit committee of CMA Alberta.

Fletcher Morgan, Executive Vice President

Dr. Morgan is a strategic and management consultant with over 10 years’ experience overseeing multi-million dollar projects and programs in the United Kingdom and Europe. Dr. Morgan has both a masters and a medical degree from Cambridge University, United Kingdom. His analytical work has included the US natural gas market and the North American Oil & Gas midstream service sector. In 2012, he acted as an advisor to one of the Big Six Canadian banks on commodity-related investment opportunities including LNG transportation. As Executive Vice President, Fletcher will maintain QE2’s corporate infrastructure and lead identification of new business opportunities, conducting required due diligence on potential targets and managing the acquisition process from scoping & planning to modeling & negotiations of final closing transactions. Currently, Dr. Morgan is working on completing his Certified Financial Analyst.

Douglas Bachman, Director

Mr. Bachman brings in excess of 25 years experience of Corporate Finance and Management from a Tier One Canadian Chartered Bank. During his financial career Doug has attained numerous top performance and achievement awards across Canada. Mr. Bachman has a Business Management Degree and numerous other courses including Financial Credit and Risk Analysis, Canadian Securities Certificate, and is a graduate of the University of Alberta Corporate Executive Program.

Joe Gagliardi, Director

Joe Gagliardi is a Certified Management Accountant and the Founding Partner of a successful Alberta-based recruiting firm, Recruitment Partners. Prior to his 8 years as a professional recruiter Mr. Gagliardi worked as a senior accounting professional with both private and publicly traded organizations, earning him a wide spectrum of experience in industrial manufacturing, oil and gas service companies, food processing and agriculture, where he has held roles from Controller to CFO. Mr. Gagliardi is an active volunteer in the business community, particularly as a Director on the Board of Directors for CMA Alberta and as the Chair of the Business Advisory Council for the J.R. Shaw School of Business (NAIT). As the CFO for QE2 Acquisition Corp., Mr. Gagliardi will work as a key member of the Executive Team on all strategic and tactical matters as they relate to the corporation’s finances. His focus will be in both the target and operational areas of budget management, cost benefit analysis, forecasting needs and the securing of new funding.

Robb McNaughton, Director

Mr. McNaughton has been a partner in the Securities and Capital Markets Group at the law firm Borden Ladner Gervais LLP since July 2013.  From March 2010 to July 2013, Mr. McNaughton was a partner in the Corporate Finance Group at the law firm Gowling Lafleur Henderson LLP.  Prior thereto, Mr. McNaughton was a lawyer and partner with Fraser Milner Casgrain LLP (currently, Dentons LLP).  Mr. McNaughton worked from September 2002 to November 2003 as the Vice-President of Strategy and Corporate Operations at Assante Corporation, which was a financial services company formerly listed on the Toronto Stock Exchange that was sold to CI Financial in 2003 for approximately $850 million. Mr. McNaughton’s professional experience includes working as an operations executive at a Japanese company based in Osaka and Tokyo. Mr. McNaughton graduated from Queen’s University with a Bachelor of Arts (Honours) degree in 1991. In 2000, Mr. McNaughton received a Bachelor of Laws degree and a Master of Business Administration degree from the University of Western Ontario’s Faculty of Law and Richard Ivey School of Business.

Maria Nathanail, Lawyer & Director

Maria Nathanail has been practicing law since 2006. Her experience has helped her to develop her excellent legal, commercial and business development skills. She is currently an associate with Burstall Winger LLP in Calgary, Alberta, practicing in the areas of securities, corporate finance, mergers and acquisitions and general corporate commercial law. Prior to that, Ms. Nathanail was an associate with Torys LLP and Gowling Lafleur Henderson LLP. Ms. Nathanail obtained a Bachelor of Arts Degree in Political Science from the University of Calgary and a Juris Doctor from the University of Saskatchewan.